Ursprung des Netzwerks ersten Grades von Todd F. Baumgartner

EinheitArt der EinheitIndustrie
Public Company Pharmaceuticals: Major 19
Public Company Pharmaceuticals: Major 17
15
Private Company Pharmaceuticals: Major 15

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Todd F. Baumgartner

UnternehmenSektorVerknüpfte PersonenHauptposition
College/University

Bridget Martell

Julia Tsai

Kevin Fitzgerald

Paula Rusu

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Masters Business Admin

Princeton University College/University

Frank Peter Boer

Jane Wasman

Kevin Fitzgerald

Undergraduate Degree

Undergraduate Degree

Doctorate Degree

MERCK & CO., INC. Pharmaceuticals: Major

Judy Lewent

Simon D. Kelner

Mark Timney

Director of Finance/CFO

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Jacqueline Le Saux

John H. Stewart

John H. Stewart

Compliance Officer

President

Chief Executive Officer

College/University

Ralph Snyderman

Gary L. Stiles

Gail Cawkwell

Corporate Officer/Principal

Corporate Officer/Principal

Undergraduate Degree

BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Jeremy Levin

Claude Nicaise

Amit Rakhit

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

PFIZER, INC. Pharmaceuticals: Major

Raul Damas

Robert Poole

Gail Cawkwell

Public Communications Contact

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Jane Wasman

Catherine D. Strader

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

BIOTIE THERAPIES CORP Pharmaceuticals: Major

Jane Wasman

Andrew Hindman

Director/Board Member

Director/Board Member

MARINUS PHARMACEUTICALS, INC. Pharmaceuticals: Major

Enrique Carrazana

Julia Tsai

Director/Board Member

Corporate Officer/Principal

Miscellaneous Commercial Services

Judy Lewent

Ralph Snyderman

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Andrew Hindman

Michael Samar

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

John H. Stewart

Mark Timney

Director/Board Member

Director/Board Member

The Trustees of Columbia University in The City of New York College/University

Andrew Hindman

Raul Damas

Masters Business Admin

Masters Business Admin

Pharmaceuticals: Major

Judy Lewent

Ralph Snyderman

Director/Board Member

Director/Board Member

Harvard Law School College/University

Bart Friedman

Jane Wasman

Graduate Degree

Graduate Degree

University of California, Berkeley College/University

Robert Poole

Amit Rakhit

Undergraduate Degree

Undergraduate Degree

Harvard Business School College/University

Bart Friedman

Paulo Costa

Corporate Officer/Principal

Masters Business Admin

Pharmaceuticals: Major

Paulo Costa

Adrian L. Rabinowicz

Chief Executive Officer

Chief Tech/Sci/R&D Officer

Medical/Nursing Services

Ralph Snyderman

Gary L. Stiles

Chief Executive Officer

Chief Tech/Sci/R&D Officer

BIOGEN INC. Pharmaceuticals: Major

Amit Rakhit

Jason Tardio

Corporate Officer/Principal

Corporate Officer/Principal

CADUS CORPORATION Biotechnology

Jeremy Levin

Suzanne K. Wakamoto

Chief Executive Officer

Chief Administrative Officer

Pharmaceuticals: Major

Paulo Costa

Peter Carbone

Chief Executive Officer

Corporate Officer/Principal

Miscellaneous Commercial Services

Jeremy Levin

Mark Timney

Director/Board Member

Director/Board Member

Villanova University College/University

Raul Damas

Michael Samar

Undergraduate Degree

Masters Business Admin

SOLID BIOSCIENCES INC. Biotechnology

Ian Smith

Martin Freed

Chairman

Director/Board Member

University of Virginia College/University

Catherine D. Strader

Anthony Caggiano

Undergraduate Degree

Undergraduate Degree

INTERCEPT PHARMACEUTICALS, INC. Pharmaceuticals: Major

Barbara Duncan

Gail Cawkwell

Director of Finance/CFO

Chief Tech/Sci/R&D Officer

Miscellaneous Commercial Services

Jeremy Levin

Jane Wasman

Director/Board Member

Director/Board Member

Biotechnology

Ralph Snyderman

Andrew Hindman

Director/Board Member

Corporate Officer/Principal

VITAE PHARMACEUTICALS INC Pharmaceuticals: Major

Martin Freed

Karen Bernstein

Chief Tech/Sci/R&D Officer

Director/Board Member

STOKE THERAPEUTICS, INC. Biotechnology

Ian Smith

Jennifer Burstein

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Susie Robinson

Robert Poole

Human Resources Officer

Corporate Officer/Principal

Miscellaneous Commercial Services

Claude Nicaise

Corporate Officer/Principal

Packaged Software

Claude Nicaise

General Counsel

SAREPTA THERAPEUTICS, INC. Pharmaceuticals: Major

Claude Nicaise

Director/Board Member

Biotechnology

Claude Nicaise

Director/Board Member

Medical/Nursing Services

Claude Nicaise

Corporate Officer/Principal

Medical/Nursing Services

Claude Nicaise

Corporate Officer/Principal

GAIN THERAPEUTICS, INC. Biotechnology

Claude Nicaise

Director/Board Member

OUTLOOK THERAPEUTICS, INC. Pharmaceuticals: Major

Claude Nicaise

Chief Tech/Sci/R&D Officer

CHEMOMAB THERAPEUTICS LTD. Biotechnology

Claude Nicaise

Director/Board Member

Miscellaneous Commercial Services

Claude Nicaise

Corporate Officer/Principal

Clinical Regulatory Services LLC

Claude Nicaise

Founder

Pharmaceuticals: Major

Simon D. Kelner

Human Resources Officer

CASSAVA SCIENCES, INC. Biotechnology

Claude Nicaise

Director/Board Member

GILEAD SCIENCES, INC. Biotechnology

Andrew Hindman

Corporate Officer/Principal

Miscellaneous Commercial Services

Susie Robinson

Corporate Officer/Principal

Statistik

International

Vereinigte Staaten 44
Vereinigtes Königreich 3
Kanada 2
Finnland 2
Spanien 2

Sektoral

Health Technology 29
Consumer Services 10
Commercial Services 8
Health Services 4
Finance 2

Operativ

Director/Board Member 162
Corporate Officer/Principal 127
Independent Dir/Board Member 59
Chief Tech/Sci/R&D Officer 48
Undergraduate Degree 41
  1. Börse
  2. Insiders
  3. Todd F. Baumgartner
  4. Unternehmensverbindungen
-40 % Einmalige Verlängerung: Unsere Abonnements führen Sie zu den besten Investitionen von morgen
PROFITIEREN SIE JETZT